Sodium phosphate laxative warnings, use limits to be subject of "feedback" meeting.
This article was originally published in The Tan Sheet
Executive Summary
SODIUM PHOSPHATE LAXATIVES NEW WARNINGS, USE LIMITS for both oral and rectal products are expected to be discussed at an OTC "feedback" meeting at FDA tentatively scheduled for July 15. In response to objections by the laxative manufacturers Nutramax and C.B. Fleet, the agency has agreed to a meeting on the new requirements, which were part of a May 21 final rule on sodium phosphate laxatives ("The Tan Sheet" May 25, p. 9). Among the companies' objections is that the warnings and directions for both types of products required by the rule were not previously proposed by the agency and therefore not subject to prior notice and comment as required by the Administrative Procedures Act.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC